AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location

Annals of Neurology

Volumn 65, Issue 4, 2009, Pages 424-434

  Lai, Meizan ^a   Hughes, Ethan G ^a   Peng, Xiaoyu ^a   Zhou, Lei ^a   Gleichman, Amy J ^a   Shu, Huidy ^b   Matá, Sabrina ^c   Kremens, Daniel ^d   Vitaliani, Roberta ^e   Geschwind, Michael D ^b   Bataller, Luis ^f   Kalb, Robert G ^g   Davis, Rebecca ^a   Graus, Francesc ^h   Lynch, David R ^a,g   Dalmau, Josep ^a   Balice Gordon, Rita ⁱ  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF FLORENCE   (Italy)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e TREVISO REGIONAL HOSPITAL   (Italy)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^h HOSPITAL CLÍNIC   (Spain)

ⁱ Hospital Clinic ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; ANTINEOPLASTIC AGENT; ANTINUCLEAR ANTIBODY; AUTOANTIGEN; AZATHIOPRINE; COLLAPSIN RESPONSE MEDIATOR PROTEIN; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; GLUTAMATE DECARBOXYLASE ANTIBODY; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; IMMUNOGLOBULIN; MEMBRANE ANTIGEN; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; PROTEIN ANTIBODY; RECEPTOR ANTIBODY; SYNAPSE RECEPTOR; TRANSCRIPTION FACTOR SOX1; AUTOANTIBODY;

ADULT; AGED; AGGRESSION; AGITATION; AMNESIA; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BEHAVIOR CHANGE; BRAIN NERVE CELL; BRAIN STEM; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER THERAPY; CAUSE OF DEATH; CELL STRAIN HEK293; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONFABULATION; CONFOCAL MICROSCOPY; CONFUSION; CORPUS CALLOSUM; CORTICOSTEROID THERAPY; DISORIENTATION; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; FOCAL EPILEPSY; GAIT DISORDER; GRAND MAL SEIZURE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HYPERSOMNIA; IMMUNOPRECIPITATION; INSOMNIA; LETHARGY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; MASS SPECTROMETRY; NERVE CELL CULTURE; NONHUMAN; NYSTAGMUS; PARANEOPLASTIC NEUROPATHY; PATHOGENESIS; PERSEVERATION; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR UPREGULATION; RELAPSE; SEIZURE; SERODIAGNOSIS; SHORT TERM MEMORY; SYNAPSE; THYMOMA; TONIC CLONIC SEIZURE; TREATMENT OUTCOME; TREATMENT RESPONSE; ANIMAL; CELL CULTURE; CYTOLOGY; GENETIC TRANSFECTION; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; METHODOLOGY; MIDDLE AGED; NEOPLASM; NERVE CELL; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, SURFACE; AUTOANTIBODIES; AUTOANTIGENS; CELLS, CULTURED; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOPRECIPITATION; IMMUNOTHERAPY; LIMBIC ENCEPHALITIS; MALE; MASS SPECTROMETRY; MIDDLE AGED; NEOPLASMS; NEURONS; RATS; RECEPTORS, AMPA; SYNAPSES; TRANSFECTION;

EID: 65649130790     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21589     Document Type: Article

References (16)

1. Corsellis JA, Goldberg GJ, Norton AR. "Limbic encephalitis" and its association with carcinoma. Brain 1968;91:481-496.
2. Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic lim- bic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000;123(pt 7):1481-1494.
3. Bataller L, Kleopa KA, Wu GF, et al. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry 2007;78:381-385.
4. Ances BM, Vitaliani R, Taylor RA, et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 2005;128:1764-1777.
5. Graus F, Saiz A, Lai M, et al. Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology 2008;71:930-936.
6. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-1098.
7. Buchhalter JR, Dichter MA. Electrophysiological comparison of pyramidal and stellate nonpyramidal neurons in dissociated cell culture of rat hippocampus. Brain Res Bull 1991;26: 333-338.
8. Elmariah SB, Oh EJ, Hughes EG, Balice-Gordon RJ. Astro- cytes regulate inhibitory synapse formation via Trk-mediated modulation of postsynaptic GABAA receptors. J Neurosci 2005;25:3638 -3650.
9. Shepherd JD, Huganir RL. The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu Rev Cell Dev Biol 2007;23:613-643.
10. Palmer CL, Cotton L, Henley JM. The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid receptors. Pharmacol Rev 2005;57: 253-277.
11. Sprengel R. Role of AMPA receptors in synaptic plasticity. Cell Tissue Res 2006;326:447-455.
12. Rogers SW, Andrews PI, Gahring LC, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994;265:648 -651.
13. Genoux D, Montgomery JM. Glutamate receptor plasticity at excitatory synapses in the brain. Clin Exp Pharmacol Physiol 2007;34:1058 -1063.
14. Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 2008;70:504-511.
15. Bernal F, Graus F, Pifarre A, et al. Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis. Acta Neuropathol (Berl) 2002;103:509 -515.
16. Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol 2008;7:327-340.